GT Biopharma
Financial ratios & Valuation

Forward Multiples (2025 – 2027)

202520262027
Price/Earnings ratio
-0.06-0.04-0.05
Price/Sales ratio
N/AN/AN/A
Earnings per Share (EPS)
$-19.2$-27.3$-23.1

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-2.38-1.733.34-15.62-3.77-0.11-0.99-1.46-1.37-1.35-0.56-3.77
Price/Sales ratio
917.052.09KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-1.90-0.91-3.758.8884.90-0.24-1.083.912.401.371.41-0.24
Price/Cash Flow ratio
-31.98-12.16-36.44-412.27-91.75-1.27-4.35-5.50-1.85-1.16-0.71-91.75
Price/Free Cash Flow ratio
-31.87-12.16-36.44-411.97-91.44-1.27-4.35-5.50-1.85-1.16-0.71-91.44
Price/Earnings Growth ratio
-0.00-0.04-0.030.150.09-0.000.020.020.010.01-0.01-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
6.55%92.59%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-3927.86%-33062.96%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-38506.55%-121207.40%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-38506.55%-121207.40%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
-21.90%-52.06%-144.56%-5.35%88.16%-5.50%-11.73%-1.17%1.82%N/AN/AN/A
Return on Assets
-2645.15%-60603.70%84132%-56.31%-1020.45%-10296.71%-558.48%-182.45%-122.50%-53.84%-175.08%-1020.45%
Return On Equity
79.88%53.07%-112.14%-56.87%-2246.17%213.02%108.03%-267.88%-174.73%-101.61%-192.41%-2246.17%
Return on Capital Employed
8.27%14.60%49.53%-53.86%-2199.37%83.14%22.98%-262.50%-180.17%-181.59%-251.84%-2199.37%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A3.35N/A
Quick Ratio
0.020.000.000.210.000.010.163.133.352.113.340.00
Cash ratio
0.020.000.000.210.000.000.150.871.140.161.140.00
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
2.63K162.97K766.5K464.64K91.87K177.02KN/AN/AN/AN/AN/A177.02K
Cash Conversion Cycle
-2.63K-162.97KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
3.78180.5496.520.000.4233.424.650.000.000.000.2933.42
Debt Equity Ratio
-0.11-0.15-0.660.000.93-0.69-0.890.000.000.000.420.42
Long-term Debt to Capitalization
-0.02-0.01N/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
-0.12-0.18-1.950.000.48-2.24-8.980.000.000.000.010.01
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-571.40N/A
Cash Flow to Debt Ratio
-0.52-0.47-0.15-175.16-0.98-0.27-0.27-503.41-138.33-152.62-133.43-0.27
Company Equity Multiplier
-0.03-0.00-0.001.002.20-0.02-0.191.461.421.881.42-0.02
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-28.67-172.48N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.001.0011.001.001111111
Cash Flow Coverage Ratio
-0.52-0.47-0.15-175.16-0.98-0.27-0.27-503.41-138.33-152.62-133.43-0.27
Short Term Coverage Ratio
-0.64-0.51-0.15-175.16-0.98-0.27-0.27-503.41-138.33-152.62-211.07-0.27
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A